(Q40780178)

23 September 2017

Which patients with hepatitis C develop liver complications? (English)

1 reference

23 September 2017

Khan MH

1

1 reference

23 September 2017

Farrell GC

2

1 reference

23 September 2017

Byth K

3

1 reference

23 September 2017

Lin R

4

1 reference

23 September 2017

Weltman M

5

1 reference

23 September 2017

George J

6

1 reference

23 September 2017

Samarasinghe D

7

1 reference

23 September 2017

Kench J

8

1 reference

23 September 2017

Kaba S

9

1 reference

23 September 2017

Crewe E

10

1 reference

23 September 2017

Liddle C

11

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

23 September 2017

1 reference

23 September 2017

31

1 reference

23 September 2017

513-520

1 reference

23 September 2017

2

1 reference

Non-A, non-B post-transfusion hepatitis. Looking back in the second decade

23 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Histopathology of chronic hepatitis C in relation to epidemiological factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Role of alcohol in the progression of liver disease caused by hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

How much does alcohol contribute to the variability of hepatic fibrosis in chronic hepatitis C?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Impact of alcohol on the histological and clinical progression of hepatitis C infection.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Dilemma of the natural history of hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Determinants of outcome of compensated hepatitis C virus-related cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Epidemiology and long term prognosis of hepatitis C virus infection in Japan

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Clinical outcome of hepatitis C as a function of mode of transmission

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Virus and host factors are both important determinants of response to interferon treatment among patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Classification of chronic viral hepatitis: a need for reassessment

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Molecular epidemiology of hepatitis C in Australia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Morbidity of chronic hepatitis C as seen in a tertiary care medical center

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Injection with nondisposable needles as an important route for transmission of acute community-acquired hepatitis C virus infection in Taiwan

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Effect of drinking on the outcome of cirrhosis in patients with hepatitis B or C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Relationship between hepatocellular carcinoma and subtypes of hepatitis C virus: a nationwide analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Long-term outcome of hepatitis C infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Liver transplantation for hepatitis C-associated cirrhosis in a single Australian centre: referral patterns and transplant outcomes.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Albumin synthesis rates in cirrhosis: correlation with Child-Turcotte classification

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Prognostic Value of Child-Turcotte Criteria in Medically Treated Cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310236

7 January 2021

Identifiers

DOI

10.1002/HEP.510310236

1 reference

23 September 2017

1 reference